Clinical Trial Update: Everolimus Plus Mycophenolic Acid for Kidney Preservation in Liver Transplant Recipients With Impaired Kidney Function [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating the combination of everolimus and mycophenolic acid for kidney preservation in liver transplant recipients with impaired ki…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Failure
• Liver Transplant-related Kidney Impairment

Drugs mentioned

• Everolimus (everolimus)
• Mycophenolic acid (mycophenolic acid)

Snippet

Sponsor: Indiana University | Conditions: Kidney Failure | Phase 3 | Status: TERMINATED | Results posted: 2023-05-24